Table 4

Estimated sensitivity of the 1997 ACR classification criteria for SLE and the 2019 EULAR/ACR classification criteria for SLE in the incident Southeast Norway SLE cohort during 2000–2017, at time of diagnosis, 2 years after diagnosis and at last visit in study period

Classification criteriaProportion of cases meeting criteria, % (95% CI) n1/n2,
At time of diagnosis2 years after diagnosis*At last visit in study period
Adult-onset SLE
Total2019 EULAR/ACR91.6 (89.5–93.6)
642/701
92.7 (90.6–94.7)
568/613
94.0 (92.3–95.8)
659/701
1997 ACR77.3 (74.2–80.4)
542/701
82.5 (79.5–85.5)
506/613
84.3 (81.6–87.0)
591/701
P<0.001P<0.001P<0.001
Female2019 EULAR/ACR92.5 (90.4–94.7)
546/590
93.6 (91.4–95.7)
480/513
94.6 (92.7–96.4)
558/590
1997 ACR79.0 (75.7–82.3)
466/590
83.6 (80.4–86.8)
429/513
85.6 (82.8–88.4)
505/590
P<0.001P<0.001P<0.001
Male2019 EULAR/ACR86.5 (80.1–92.8)
96/111
88.0 (81.6–94.4)
88/100
91.0 (85.7–96.3)
101/111
1997 ACR68.5 (59.8–77.1)
76/111
77.0 (68.6–85.2)
77/100
77.5 (69.7–85.2)
86/111
P<0.001P<0.05P<0.05
Juvenile-onset SLE‡
Total2019 EULAR/ACR97.2 (91.9–102.6)
35/36
100 (100–100)
25/25
97.2 (91.9–102.6)
35/36
1997 ACR88.9 (78.6–99.2)
32/36
92.0 (81.4–102.6)
23/25
91.7 (82.6–100.7)
33/36
Female2019 EULAR/ACR96.6 (89.9–103.1)
28/29
100 (100–100)
21/21
96.6 (89.9–103.2)
28/29
1997 ACR89.7 (78.5–100.7)
26/29
90.5 (77.9–102.6)
19/21
89.7 (78.6–100.7)
26/29
Male2019 EULAR/ACR100†
7/7
100†
4/4
100†
7/7
1997 ACR85.7†
6/7
100†
4/4
100†
7/7
  • 1997 ACR criteria, 1997 ACR classification criteria for SLE; 2019 EULAR/ACR criteria, 2019 EULAR/ACR classification criteria for SLE.

  • n1, number of cases fulfilling the criteria; n2,, total number of cases at visit

  • *Estimated sensitivity 2 years after diagnosis includes only the 638 incident cases during 2000–2015 to allow for 2-year follow-up for all cases.

  • †Less than 10 cases and to scarce for statistical analysis.

  • ‡2019 EULAR/ACR criteria fulfilment vs 1997 ACR criteria fulfilment did not differ significantly.

  • EULAR/ACR, European Alliance of Associations for Rheumatology/American College of Rheumatology; SLE, systemic lupus erythematosus.